Cargando…

Ad26.COV2-S: Transient thrombocytopenia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795319/ http://dx.doi.org/10.1007/s40278-022-09266-6

Ejemplares similares

Ad26.cov2-s: Pulmonary embolism, transient ischaemic attack and thrombocytopenia: case report
Publicado: (2021)

Ad26.cov2-s: Thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: case report
Publicado: (2022)

Ad26.COV2-S: Immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Immune-thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: 3 case reports
Publicado: (2021)

Ad26.COV2-S/AZD-1222: Thrombotic thrombocytopenia: 5 case reports
Publicado: (2022)

Ad26.CoV2-S/elasomeran: Thrombosis with thrombocytopenia syndrome: 6 case reports
Publicado: (2022)

Ad26.cov2-s/immune-globulin: Immune mediated thrombocytopenia and no response: case report
Publicado: (2021)

Ad26.COV2-S: Cerebral Venous Sinus Thrombosis with Thrombocytopenia: 14 case reports
Publicado: (2021)

Ad26.COV2-S: Thrombotic thrombocytopenia and cerebral venous sinus thrombosis: case report
Publicado: (2021)

Ad26.cov2-s/AZD-1222: Cerebral venous sinus thrombosis and thrombotic thrombocytopenia: 3 case reports
Publicado: (2022)

Ad26.cov2-s: Myocarditis: case report
Publicado: (2021)

Ad26.cov2-s: Rhabdomyolysis: case report
Publicado: (2021)

Ad26.cov2-s/covid-19-vaccine-pfizer-biontech/gsk-137173a: Thrombocytopenia: 3 case reports
Publicado: (2021)

Ad26.cov2-s: Bell's palsy: case report
Publicado: (2022)

Ad26.COV2-S: Thrombocythemia-thrombotic: case report
Publicado: (2022)

Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
por: Antonios, Bana, et al.
Publicado: (2022)

Ad26.COV2-S: Multisystem inflammatory syndrome: case report
Publicado: (2022)

Ad26.COV2-S: Cerebral venous thrombosis: case report
Publicado: (2022)

Ad26.cov2-s: Inflammatory heart disease: case report
Publicado: (2022)

Ad26.cov2-s: Diffuse erythematous dermatitis: case report
Publicado: (2022)

Ad26.cov2-s: Thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Ad26.cov2 S: Guillian Barre syndrome: case report
Publicado: (2022)

Ad26.COV2-S: Cerebral venous thrombosis: case report
Publicado: (2022)

Ad26.COV2-S: Guillain-Barre syndrome: case report
Publicado: (2021)

Ad26.COV2-S: Deep venous thrombosis: case report
Publicado: (2021)

Ad26.cov2-s: Portal vein thrombosis: case report
Publicado: (2021)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
por: Muir, Kate-Lynn, et al.
Publicado: (2021)

Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US
por: Rodriguez, Elsa V. C., et al.
Publicado: (2021)

Ad26.COV2-S/elasomeran/tozinameran: Myocarditis: 7 case reports
Publicado: (2022)

Ad26.CoV2-S/heparin: Various toxicities: case report
Publicado: (2021)

Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination
por: Curcio, Rosa, et al.
Publicado: (2022)

Ad26.cov2-s: Guillain Barre syndrome and fulminant encephalomyelitis: case report
Publicado: (2022)

Ad26.cov2-s: Fatigue, fever and hypertensive crisis: 3 case reports
Publicado: (2022)

Ad26.cov2-s/immune-globulin: Guillain barre syndrome and pseudohyponatraemia: case report
Publicado: (2022)

Ad26.cov2-s/elasomeran/tozinameran: Vaccine breakthrough infection: 76 case reports
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o6ra15r3cso7fk3747vj8imhm2